Jabra Enhance Select 200 vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #22 among 39 prescription hearing aids tested. This device demonstrates notable strengths in speech clarity and feedback control. Speech in quiet scored 4.0/5, which is 0.57 points above the category average—a meaningful advantage for everyday conversations. Feedback handling achieved a perfect 5.0/5, sitting 0.28 points above the already-high category average of 4.72/5. Own-voice comfort also performed well at 3.2/5, exceeding the category average by 0.50 points. Speech in noise presents a more mixed picture. While the 2.2/5 score is technically above the category average by 0.10 points, it remains modest in absolute terms—something to consider if challenging listening environments are a priority. Music streaming scored a solid 3.0/5, sitting 0.24 points above average. The Pure C&G IX features rechargeable batteries and supports streaming to both iPhone and Android devices, including hands-free calling. At this premium price point, competitors like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieve higher overall scores. This device may suit those who prioritize clear speech in quieter settings and excellent feedback stability, though buyers seeking stronger noise performance may want to compare alternatives.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit